Hydrogen‐Bonded Organic Framework Nanoscintillators for X‐Ray‐Induced Photodynamic Therapy in Hepatocellular Carcinoma
Source abstract
Abstract
Abstract X‐ray induced photodynamic therapy (X‐PDT) leverages penetrating X‐ray to generate singlet oxygen ( 1 O 2 ) for treating deep‐seated tumors. However, conventional X‐PDT typically relies on heavy metal inorganic scintillators and organic photosensitizers to produce 1 O 2 , which presents challenges related to toxicity and energy conversion efficiency. In this study, highly biocompatible organic phosphorescent nanoscintillators based on hydrogen‐bonded organic frameworks (HOF) are designed and engineered, termed BPT‐HOF@PEG, to enhance X‐PDT in hepatocellular carcinoma (HCC) treatment. BPT‐HOF@PEG functions simultaneously as both scintillator and photosensitizer, effectively absorbing and transferring X‐ray energy to generate abundant 1 O 2 . Both in vitro and in vivo investigations demonstrate that internalized BPT‐HOF@PEG efficiently produces significant quantities of 1 O 2 upon X‐ray irradiation. Additionally, X‐ray exposure directly inflicts DNA damage, and the synergistic effects of these mechanisms result in pronounced cell death and substantial tumor growth inhibition, with a significant inhibition rate of up to 90.4% in vivo assessments. RNA sequencing analyses reveal that X‐PDT induces apoptosis in Hepa1‐6 cells while inhibiting cell proliferation, culminating in tumor cell death. Therefore, this work highlights the considerable potential of efficient phosphorescent HOF nanoscintillators‐based X‐PDT as a promising therapeutic approach for HCC, providing a highly effective alternative with negligible toxicity for patients with unresectable tumors.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Metal-Organic Frameworks: Synthesis and Applications · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Hepatobiliary Surgery Eastern Hepatobiliary Surgery Hospital Naval Medical University Shanghai 200438 P. R. China
Department of Colorectal Surgery The First Affiliated Hospital of Naval Medical University Shanghai 200433 P. R. China
Department of Graduate Bengbu Medical University Bengbu 233099 P. R. China
School of Life Sciences Shanghai University Shanghai 200444 P. R. China
Funding
Shanghai Rising-Star Program · National Natural Science Foundation of China
References (58)
Show source-provided references
1. 10.1016/S0140-6736(23)01857-310.1016/S0140-6736(23)01857-3 ↗
2. 10.1016/S0140-6736(23)01384-310.1016/S0140-6736(23)01384-3 ↗
3. 10.1200/JCO.23.0098510.1200/JCO.23.00985 ↗
4. 10.1016/j.semcancer.2023.11.00610.1016/j.semcancer.2023.11.006 ↗
5. 10.1158/2159-8290.CD-22-019210.1158/2159-8290.CD-22-0192 ↗
6. 10.1038/s44222-024-00196-z10.1038/s44222-024-00196-z ↗
7. 10.1038/s41557-023-01242-w10.1038/s41557-023-01242-w ↗
8. 10.1038/s41467-023-43890-z10.1038/s41467-023-43890-z ↗
9. 10.1021/acs.chemrev.4c0010510.1021/acs.chemrev.4c00105 ↗
10. 10.1002/adma.20240272010.1002/adma.202402720 ↗
11. 10.1007/s40820-022-00856-y10.1007/s40820-022-00856-y ↗
12. 10.1002/adma.20240602610.1002/adma.202406026 ↗
13. 10.1002/adma.20240547510.1002/adma.202405475 ↗
14. 10.1002/anie.20241180210.1002/anie.202411802 ↗
15. 10.1002/adfm.20230520210.1002/adfm.202305202 ↗
16. 10.1002/adma.20240719910.1002/adma.202407199 ↗
17. 10.1038/s41377-024-01437-x10.1038/s41377-024-01437-x ↗
18. 10.1002/adma.20230953410.1002/adma.202309534 ↗
19. 10.1039/D1CS01145F10.1039/D1CS01145F ↗
20. 10.1038/s41467-024-47559-z10.1038/s41467-024-47559-z ↗
21. 10.1002/advs.20230239510.1002/advs.202302395 ↗
22. 10.1002/anie.20190871210.1002/anie.201908712 ↗
23. 10.1002/smll.20210765610.1002/smll.202107656 ↗
24. 10.1021/acsnano.2c0804710.1021/acsnano.2c08047 ↗
25. 10.1002/adhm.20240037210.1002/adhm.202400372 ↗
26. 10.1016/j.bioactmat.2021.05.01610.1016/j.bioactmat.2021.05.016 ↗
27. 10.1021/acsnano.2c0728610.1021/acsnano.2c07286 ↗
28. 10.1002/adma.20180802410.1002/adma.201808024 ↗
29. 10.1002/advs.20200333810.1002/advs.202003338 ↗
30. 10.1002/advs.20240203910.1002/advs.202402039 ↗
31. 10.1002/adma.20230222010.1002/adma.202302220 ↗
32. 10.1001/jamaoncol.2021.596410.1001/jamaoncol.2021.5964 ↗
33. 10.1038/s41586-023-06233-y10.1038/s41586-023-06233-y ↗
34. 10.1038/s41467-022-32054-010.1038/s41467-022-32054-0 ↗
35. 10.1021/acs.accounts.2c0030710.1021/acs.accounts.2c00307 ↗
36. 10.1021/jacs.4c0536410.1021/jacs.4c05364 ↗
37. 10.1039/D2CS00993E10.1039/D2CS00993E ↗
38. 10.1002/adma.20221185810.1002/adma.202211858 ↗
39. 10.1002/adma.20240149310.1002/adma.202401493 ↗
40. 10.1002/smll.20230727710.1002/smll.202307277 ↗
41. 10.1002/anie.20231581710.1002/anie.202315817 ↗
42. 10.1038/s41557-022-01070-410.1038/s41557-022-01070-4 ↗
43. 10.1038/s41467-022-30368-710.1038/s41467-022-30368-7 ↗
44. 10.1002/anie.20180069710.1002/anie.201800697 ↗
45. 10.1021/acs.accounts.2c0051410.1021/acs.accounts.2c00514 ↗
46. 10.1002/anie.20231389010.1002/anie.202313890 ↗
47. 10.1002/anie.20230098010.1002/anie.202300980 ↗
48. 10.1039/D3CS01026K10.1039/D3CS01026K ↗
49. 10.1002/anie.20240074210.1002/anie.202400742 ↗
50. 10.1039/D3CS00408B10.1039/D3CS00408B ↗
51. 10.1016/j.scib.2024.02.00810.1016/j.scib.2024.02.008 ↗
52. 10.1038/s41467-024-48715-110.1038/s41467-024-48715-1 ↗
53. 10.1002/adma.20240392110.1002/adma.202403921 ↗
54. 10.1186/s13046-022-02260-110.1186/s13046-022-02260-1 ↗
55. 10.1038/s41388-020-1363-810.1038/s41388-020-1363-8 ↗
56. 10.3390/ijms2503184810.3390/ijms25031848 ↗
57. 10.1016/j.annonc.2023.01.00910.1016/j.annonc.2023.01.009 ↗
58. 10.1158/1078-0432.CCR-14-140310.1158/1078-0432.CCR-14-1403 ↗